Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial

Prasanna Jagannathan(Palo Alto University), Grant Dorsey(University of California System), Miriam Nakalembe(Makerere University), Linda Reiling(Burnet Institute), Mary Prahl(University of California, San Francisco), Paul Natureeba(Infectious Diseases Research Collaboration), Chris Drakeley(London School of Hygiene & Tropical Medicine), Kevin K. A. Tetteh(London School of Hygiene & Tropical Medicine), Tamara D. Clark(University of California, San Francisco), Isabel Rodríguez-Barraquer(University of California, San Francisco), Mary Muhindo(Infectious Diseases Research Collaboration), Jaffer Okiring(Africa Center), Bryan Greenhouse(University of California, San Francisco), Felistas Nankya(Infectious Diseases Research Collaboration), Francesca Aweeka(University of California, San Francisco), Margaret E. Feeney(San Francisco General Hospital), Erika Wallender(University of California, San Francisco), Abel Kakuru(Infectious Diseases Research Collaboration), Bishop Opira(Infectious Diseases Research Collaboration), Diane V. Havlir(University of California, San Francisco), James G. Beeson(Burnet Institute), Moses R. Kamya(University of London), Edwin D. Charlebois, Isaac Ssewanyana(Infectious Diseases Research Collaboration), Peter Olwoch(Infectious Diseases Research Collaboration)
PLoS Medicine
July 17, 2018
Cited by 29


Related Papers